{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:22:17Z","timestamp":1785435737995,"version":"3.56.0"},"reference-count":137,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1F30CA298656-01A1"],"award-info":[{"award-number":["1F30CA298656-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1F30CA298656-01A1"],"award-info":[{"award-number":["1F30CA298656-01A1"]}],"id":[{"id":"https:\/\/ror.org\/040gcmg81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Myeloid-derived suppressor cells (MDSCs) are a class of immature, heterogenous, and functionally immunosuppressive myeloid progenitors that are expanded in malignant disease including glioblastoma (GBM). Extensive preclinical evaluation of GBM has revealed that MDSCs express multiple different chemokine and cytokine receptors that facilitate their entry, infiltration, expansion and immunosuppression of antitumor immunity in the tumor microenvironment. Additionally, translational investigation of approaches that target MDSCs directly or indirectly through immune remodeling has yielded promising effects that are under clinical trial investigation. Given the immunosuppressive phenotype of high-grade gliomas like GBM, the removal of MDSCs represents a clinically relevant strategy to enhance immune responses against neoplastic cells. In this review, we provide a comprehensive summary of MDSCs in GBM, emphasizing clinical observations and large-scale multi-omics studies that position MDSCs at the nexus of GBM immunosuppression. Next, we provide detailed coverage of multiple chemokines, cytokines, and growth factors that are relevant to MDSC migration, survival and expansion in GBM along with commentary on the associated receptors. Lastly, we discuss therapeutic approaches that directly target MDSCs as a strategy to improve immune responses against malignant brains and observations on the changes to MDSCs in the tumor microenvironment after immunotherapy. Our review serves as a valuable resource for the neuro-oncology research space, updating scientists and clinicians on a cell central to the biology and therapeutic targeting of GBM.<\/jats:p>","DOI":"10.3390\/cells15121099","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:19:53Z","timestamp":1781691593000},"page":"1099","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myeloid-Derived Suppressor Cells: Function, Migration, and Therapeutic Opportunities in Glioblastoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-1094","authenticated-orcid":false,"given":"John W.","family":"Figg","sequence":"first","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-0698","authenticated-orcid":false,"given":"Caitland","family":"Love","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illeana","family":"West","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-9674","authenticated-orcid":false,"given":"Dan","family":"Jin","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Engelbart","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Ware","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Bessey","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine T.","family":"Flores","sequence":"additional","affiliation":[{"name":"Preston A. Wells Jr. Center for Brain Tumor Therapy, Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Yalamarty, S.S.K., Filipczak, N., Li, X., Subhan, A., Parveen, F., Ataide, J.A., Rajmalani, B.A., and Torchilin, V.P. (2023). Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM). Cancers, 15.","DOI":"10.3390\/cancers15072116"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/2159-8290.CD-20-0057","article-title":"Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas","volume":"10","author":"Pine","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Khan, S., Mahalingam, R., Sen, S., Martinez-Ledesma, E., Khan, A., Gandy, K., Lang, F.F., Sulman, E.P., Alfaro-Munoz, K.D., and Majd, N.K. (2021). Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells. Cancers, 13.","DOI":"10.3390\/cancers13215284"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Musca, B., Russo, M.G., Tushe, A., Magri, S., Battaggia, G., Pinton, L., Bonaudo, C., Della Puppa, A., and Mandruzzato, S. (2023). The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1236824"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lakshmanachetty, S., Cruz-Cruz, J., Hoffmeyer, E., Cole, A.P., and Mitra, S.S. (2021). New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs. Cells, 10.","DOI":"10.3390\/cells10040893"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"eabm5214","DOI":"10.1126\/science.abm5214","article-title":"Distinct myeloid-derived suppressor cell populations in human glioblastoma","volume":"387","author":"Jackson","year":"2025","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e122264","DOI":"10.1172\/jci.insight.122264","article-title":"Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis","volume":"3","author":"Alban","year":"2018","journal-title":"JCI Insight"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41577-024-01062-0","article-title":"Defining myeloid-derived suppressor cells","volume":"24","author":"Akkari","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V96.12.3838","article-title":"Identification of a CD11b(+)\/Gr-1(+)\/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells","volume":"96","author":"Bronte","year":"2000","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The Terminology Issue for Myeloid-Derived Suppressor Cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e004805","DOI":"10.1136\/jitc-2022-004805","article-title":"Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis","volume":"11","author":"Dean","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"vdag054","DOI":"10.1093\/noajnl\/vdag054","article-title":"Adoptive cellular therapy prevents reconstitution of myeloid-derived suppressor cells in the glioma tumor microenvironment","volume":"8","author":"Figg","year":"2026","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"167498","DOI":"10.1016\/j.bbadis.2024.167498","article-title":"S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130\/JAK2\/STAT3 signaling in acute myeloid leukemia","volume":"1871","author":"Peng","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1126\/scitranslmed.abn6758","article-title":"Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma","volume":"15","author":"Ghosh","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sloan, L., Sen, R., Liu, C., Doucet, M., Blosser, L., Katulis, L., Kamson, D.O., Grossman, S., Holdhoff, M., and Redmond, K.J. (2024). Radiation immunodynamics in patients with glioblastoma receiving chemoradiation. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1438044"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41590-022-01215-0","article-title":"Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression","volume":"23","author":"Yeo","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.ijpt.2024.100633","article-title":"The Level of Circulating M-MDSCs as an Indicator for the Therapeutic Outcome of BNCT in End-Stage Malignant Brain Tumor Patients","volume":"14","author":"Chang","year":"2024","journal-title":"Int. J. Part. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-19-1355","article-title":"Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner","volume":"10","author":"Bayik","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1158\/0008-5472.CAN-21-3840","article-title":"Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets","volume":"82","author":"Bayik","year":"2022","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.166.9.5398","article-title":"Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells","volume":"166","author":"Gabrilovich","year":"2001","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2010.03.011","article-title":"Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model","volume":"223","author":"Jia","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","article-title":"Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species","volume":"172","author":"Kusmartsev","year":"2004","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.4049\/jimmunol.0902661","article-title":"Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells","volume":"184","author":"Nagaraj","year":"2010","journal-title":"J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine","volume":"70","author":"Srivastava","year":"2010","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Dai, Z., Wang, Y., Sun, N., and Zhang, C. (2024). Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1299953"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","year":"2013","journal-title":"Inflammopharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.it.2023.10.003","article-title":"Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis","volume":"44","author":"Russo","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Takacs, G.P., Kreiger, C.J., Luo, D., Tian, G., Garcia, J.S., Deleyrolle, L.P., Mitchell, D.A., and Harrison, J.K. (2023). Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+\/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.993444"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"viii255","DOI":"10.1093\/neuonc\/noae165.1009","article-title":"EXTH-79. Breaking the Barrier: Adoptive Cellular Therapy Halts Glioma Immunosuppression by Targeting Myeloid-Derived Suppressor Cell Migration and Cell Cycle Mechanisms","volume":"26","author":"Figg","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"v364","DOI":"10.1093\/neuonc\/noaf201.1441","article-title":"EXTH-108. Adoptive cellular therapy disrupts macrophage-derived CCL12 signaling to inhibit myeloid-derived suppressor cell migration in glioma","volume":"27","author":"Figg","year":"2025","journal-title":"Neuro-Oncology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41590-024-02068-5","article-title":"The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer","volume":"26","author":"He","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/carcin\/bgac032","article-title":"Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells","volume":"43","author":"Mise","year":"2022","journal-title":"Carcinogenesis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-21-2347","article-title":"NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy","volume":"28","author":"Otani","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Chen, J., Wu, Q., Berglund, A.E., Macaulay, R.J., Mul\u00e9, J.J., and Etame, A.B. (2025). Tumor-Associated Macrophages in Glioblastoma: Mechanisms of Tumor Progression and Therapeutic Strategies. Cells, 14.","DOI":"10.3390\/cells14181458"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","article-title":"FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2","volume":"79","author":"Xie","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101806","DOI":"10.1016\/j.xcrm.2024.101806","article-title":"Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function","volume":"12","author":"Chun","year":"2015","journal-title":"Cell Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gu, P., Sun, M., Li, L., Yang, Y., Jiang, Z., Ge, Y., Wang, W., Mu, W., and Wang, H. (2021). Breast Tumor-Derived Exosomal MicroRNA-200b-3p Promotes Specific Organ Metastasis Through Regulating CCL2 Expression in Lung Epithelial Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.657158"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-010-0473-5","article-title":"Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy","volume":"104","author":"Zhu","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.1910856117","article-title":"CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas","volume":"117","author":"Luo","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e008722","DOI":"10.1136\/jitc-2023-008722","article-title":"CCR5 and CCL5 in metastatic colorectal cancer","volume":"12","author":"Schlechter","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e011108","DOI":"10.1136\/jitc-2024-011108","article-title":"METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation","volume":"13","author":"Tong","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"109372","DOI":"10.1016\/j.intimp.2022.109372","article-title":"Chemokine CCL5 immune subtypes of human liver cancer with prognostic significance","volume":"113","author":"Xia","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2338965","DOI":"10.1080\/2162402X.2024.2338965","article-title":"CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy","volume":"13","author":"Pant","year":"2024","journal-title":"Oncoimmunology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e00853","DOI":"10.1016\/j.neurot.2026.e00853","article-title":"KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma","volume":"23","author":"Ahn","year":"2026","journal-title":"Neurotherapeutics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eabc2511","DOI":"10.1126\/sciadv.abc2511","article-title":"Regulation of tumor immune suppression and cancer cell survival by CXCL1\/2 elevation in glioblastoma multiforme","volume":"7","author":"Hu","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.apsb.2023.09.005","article-title":"ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1158\/1078-0432.CCR-21-1392","article-title":"Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma","volume":"27","author":"Zhai","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/2326-6066.CIR-22-0655","article-title":"Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma","volume":"11","author":"Yeo","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e175147","DOI":"10.1172\/JCI175147","article-title":"Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cells","volume":"134","author":"Imperatore","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-019-03172-5","article-title":"Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment","volume":"143","author":"Wu","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1021\/acsnano.1c07492","article-title":"Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy","volume":"16","author":"Alghamri","year":"2022","journal-title":"ACS Nano"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomater."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"123216","DOI":"10.1016\/j.biomaterials.2025.123216","article-title":"Immunity\/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12\/CXCR4 and adenosine-A2AR pathways","volume":"319","author":"Wei","year":"2025","journal-title":"Biomaterials"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ccell.2023.03.004","article-title":"Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s43018-021-00227-3","article-title":"Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression","volume":"2","author":"Haffner","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155828","DOI":"10.1016\/j.cyto.2022.155828","article-title":"Interleukin-8: An evolving chemokine","volume":"153","author":"Matsushima","year":"2022","journal-title":"Cytokine"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Tobin, R.P., Jordan, K.R., Kapoor, P., Spongberg, E., Davis, D., Vorwald, V.M., Couts, K.L., Gao, D., Smith, D.E., and Borgers, J.S.W. (2019). IL-6 and IL-8 Are Linked with Myeloid-Derived Suppressor Cell Accumulation and Correlate with Poor Clinical Outcomes in Melanoma Patients. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01223"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Takacs, G.P., Garcia, J.S., Hodges, C.A., Kreiger, C.J., Sherman, A., and Harrison, J.K. (2024). CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner. Cancers, 16.","DOI":"10.3390\/cancers16173055"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2219164","DOI":"10.1080\/2162402X.2023.2219164","article-title":"Decreased melanoma CSF-1 secretion by Cannabigerol treatment reprograms regulatory myeloid cells and reduces tumor progression","volume":"12","author":"Wyrobnik","year":"2023","journal-title":"Oncoimmunology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1010428317699797","DOI":"10.1177\/1010428317699797","article-title":"Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin","volume":"39","author":"Kast","year":"2017","journal-title":"Tumour Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41388-021-02132-6","article-title":"CD73 induces GM-CSF\/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis","volume":"41","author":"King","year":"2022","journal-title":"Oncogene"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1038\/onc.2016.516","article-title":"Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation","volume":"36","author":"Lin","year":"2017","journal-title":"Oncogene"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40001-022-00788-8","article-title":"GM-CSF-mediated inducement of bone marrow MDSCs by TSA and effect on survival of graft in mice","volume":"27","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1158\/0008-5472.CAN-12-4124","article-title":"GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-\u03b1","volume":"73","author":"Kohanbash","year":"2013","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/bloodadvances.2017006858","article-title":"Novel GM-CSF signals via IFN-\u03b3R\/IRF-1 and AKT\/mTOR license monocytes for suppressor function","volume":"1","author":"Ribechini","year":"2017","journal-title":"Blood Adv."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Alban, T.J., Bayik, D., Otvos, B., Rabljenovic, A., Leng, L., Jia-Shiun, L., Roversi, G., Lauko, A., Momin, A.A., and Mohammadi, A.M. (2020). Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01191"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1158\/1078-0432.CCR-10-0644","article-title":"Role of type 1 IFNs in antiglioma immunosurveillance\u2014Using mouse studies to guide examination of novel prognostic markers in humans","volume":"16","author":"Fujita","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/0008-5472.CAN-10-2670","article-title":"Myeloid derived suppressor cell inhibition of the IFN response in tumor-bearing mice","volume":"71","author":"Lesinski","year":"2011","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00109-012-0916-x","article-title":"Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells","volume":"90","author":"Wu","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","article-title":"Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.18632\/oncotarget.2368","article-title":"IL-6-stimulated CD11b+ CD14+ HLA-DR\u2212 myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus","volume":"5","author":"Chen","year":"2014","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.oraloncology.2019.02.027","article-title":"The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling","volume":"91","author":"Tsai","year":"2019","journal-title":"Oral. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1748-717X-8-159","article-title":"The role of IL-6 in the radiation response of prostate cancer","volume":"8","author":"Wu","year":"2013","journal-title":"Radiat. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"218303","DOI":"10.1016\/j.canlet.2026.218303","article-title":"Treg-driven magnetic resonance radiomics in glioblastoma: A multicenter and cross-species model for prognostic biomarker discovery","volume":"642","author":"Wang","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41416-021-01515-6","article-title":"IL-10 in glioma","volume":"125","author":"Widodo","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"200111","DOI":"10.1098\/rsob.200111","article-title":"Mechanisms of immune suppression by myeloid-derived suppressor cells: The role of interleukin-10 as a key immunoregulatory cytokine","volume":"10","author":"Yaseen","year":"2020","journal-title":"Open Biol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hart, K.M., Byrne, K.T., Molloy, M.J., Usherwood, E.M., and Berwin, B. (2011). IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer. Front. Immunol., 2.","DOI":"10.3389\/fimmu.2011.00029"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1016\/j.celrep.2018.11.050","article-title":"Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis","volume":"25","author":"Ibrahim","year":"2018","journal-title":"Cell Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/2767-9764.CRC-23-0189","article-title":"NLRP3 Inflammasome Activation Expands the Immunosuppressive Myeloid Stroma and Antagonizes the Therapeutic Benefit of STING Activation in Glioblastoma","volume":"5","author":"Lea","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"166","DOI":"10.24976\/Discov.Med.202537192.14","article-title":"Glioblastoma Stem Cells: MAP17 as a Novel Predictive Biomarker and Therapeutic Target Associated with Quiescence and Immune Evasion","volume":"37","author":"Aghamiri","year":"2025","journal-title":"Discov. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"vdac017","DOI":"10.1093\/noajnl\/vdac017","article-title":"Superinduction of immunosuppressive glioblastoma extracellular vesicles by IFN-\u03b3 through PD-L1 and IDO1","volume":"4","author":"Jung","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/neuonc\/noae149","article-title":"Interferon regulatory factor 8-driven reprogramming of the immune microenvironment enhances antitumor adaptive immunity and reduces immunosuppression in murine glioblastoma","volume":"26","author":"Montoya","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Tian, Y., Gao, X., Yang, X., Chen, S., and Ren, Y. (2024). VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12803-8"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chen, J.-Y., Lai, Y.-S., Chu, P.-Y., Chan, S.-H., Wang, L.-H., and Hung, W.-C. (2019). Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment. Cancers, 11.","DOI":"10.3390\/cancers11081120"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e1490853","DOI":"10.1080\/2162402X.2018.1490853","article-title":"TGF-\u03b21 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy","volume":"7","author":"Jayaraman","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00262-021-03081-5","article-title":"TGF-\u03b2 orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer","volume":"71","author":"Gneo","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Cao, P., Sun, Z., Zhang, F., Zhang, J., Zheng, X., Yu, B., Zhao, Y., Wang, W., and Wang, W. (2022). TGF-\u03b2 Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.919674"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Irshad, K., Srivastava, C., Malik, N., Arora, M., Gupta, Y., Goswami, S., Sarkar, C., Suri, V., Mahajan, S., and Gupta, D.K. (2022). Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment via TGF-\u03b2. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.813888"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e29949","DOI":"10.1016\/j.heliyon.2024.e29949","article-title":"Glioma-derived exosome Lncrna Agap2-As1 promotes glioma proliferation and metastasis by mediating Tgf-\u03b21 secretion of myeloid-derived suppressor cells","volume":"10","author":"Tian","year":"2024","journal-title":"Heliyon"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Zhu, Q., Wei, J., and Han, W. (2025). Dual-Faced Role of GDF6 in Cancer: Mechanistic Insights into Its Context-Dependent Regulation of Metastasis and Immune Evasion Across Human Malignancies. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47040249"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1084\/jem.20062602","article-title":"MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis","volume":"204","author":"Delano","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_108","first-page":"4441","article-title":"All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination","volume":"63","author":"Kusmartsev","year":"2003","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1158\/0008-5472.CAN-07-2593","article-title":"Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells","volume":"67","author":"Nefedova","year":"2007","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1158\/1078-0432.CCR-22-2495","article-title":"Targeting MDSC differentiation using ATRA: A phase I\/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma","volume":"29","author":"Tobin","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1158\/1078-0432.CCR-09-3272","article-title":"Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer","volume":"16","author":"Nagaraj","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"vdad088","DOI":"10.1093\/noajnl\/vdad088","article-title":"A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma","volume":"5","author":"Ghosh","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-015-1720-6","article-title":"Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes","volume":"122","author":"Raychaudhuri","year":"2015","journal-title":"J. Neuro-Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ymthe.2016.10.003","article-title":"Immunosuppressive Myeloid Cells\u2019 Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy","volume":"25","author":"Kamran","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e130748","DOI":"10.1172\/jci.insight.130748","article-title":"Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells","volume":"4","author":"Peereboom","year":"2019","journal-title":"JCI Insight"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2423983","DOI":"10.1080\/2162402X.2024.2423983","article-title":"FGL2172-220 peptides improve the antitumor effect of HCMV-IE1mut vaccine against glioblastoma by modulating immunosuppressive cells in the tumor microenvironment","volume":"13","author":"Wang","year":"2024","journal-title":"Oncoimmunology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","article-title":"COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells","volume":"71","author":"Fujita","year":"2011","journal-title":"Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/2326-6066.CIR-18-0865","article-title":"Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF","volume":"7","author":"Macas","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e006239","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e177141","DOI":"10.1172\/jci.insight.177141","article-title":"Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment","volume":"9","author":"Hatae","year":"2024","journal-title":"JCI Insight"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1038\/s41467-018-06182-5","article-title":"Lin\u2212CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-17-3061","article-title":"Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma","volume":"24","author":"Wildes","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/jnci\/85.22.1836","article-title":"Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma","volume":"85","author":"Kuratsu","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"104277","DOI":"10.1016\/j.cellimm.2020.104277","article-title":"Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy","volume":"361","author":"Innamarato","year":"2021","journal-title":"Cell. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.ymthe.2020.06.025","article-title":"Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy","volume":"28","author":"Innamarato","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: Current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41591-018-0135-2","article-title":"Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors","volume":"24","author":"Chongsathidkiet","year":"2018","journal-title":"Nat. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41467-022-28175-1","article-title":"Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesis","volume":"13","author":"Fielding","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"eaay9368","DOI":"10.1126\/sciimmunol.aay9368","article-title":"Sympathetic nervous tone limits the development of myeloid-derived suppressor cells","volume":"5","author":"Nevin","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.immuni.2024.09.007","article-title":"Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations","volume":"57","author":"Ross","year":"2024","journal-title":"Immunity"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Scheyltjens","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e20230062","DOI":"10.1002\/INMD.20230062","article-title":"PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI-based approach for future drug repurposing exploration","volume":"2","author":"Zhang","year":"2024","journal-title":"Interdiscip. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/s41467-019-11869-4","article-title":"CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors","volume":"10","author":"Jin","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1078-0432.CCR-13-0709","article-title":"EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss","volume":"20","author":"Sampson","year":"2014","journal-title":"Clin. Cancer Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/12\/1099\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:42:49Z","timestamp":1781692969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/12\/1099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":137,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cells15121099"],"URL":"https:\/\/doi.org\/10.3390\/cells15121099","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}